MedTrace Logo

Prospective Evaluation of a Commercially Available Hydrogel Spacer

NCT05323747 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2025-09-16

No results posted yet for this study

Summary

Dosimetry efficacy evaluation of the hydrogel spacer

Conditions

Interventions

OTHER

Observation

Assessment of rectal dosimetry change from pre-insertion to post-insertion in subjects with prostate cancer who have undergone radiotherapy with a hydrogel spacer.

Sponsors & Collaborators

  • BioProtect

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-20
Primary Completion
2021-06-29
Completion
2022-02-08

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05323747 on ClinicalTrials.gov